Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide Comparison

NAD+vsSS-31 (Elamipretide)

Your cells' master energy currency and anti-aging powerhouse—NAD+ keeps your mitochondria humming, activates longevity genes called sirtuins, and helps repair DNA damage that accumulates as you get older.

A revolutionary mitochondria-targeting peptide that works like a direct energy boost for your cells—binding to cardiolipin in your mitochondria to supercharge ATP production, reduce oxidative stress, and protect your cellular powerhouses from age-related decline.

MitochondrialMitochondrial

At a Glance

Quick
comparison

Dose Range

NAD+

250–500 mg

SS-31 (Elamipretide)

5–40 mg

Frequency

NAD+

Once daily

SS-31 (Elamipretide)

Once daily

Administration

NAD+

Oral (NR or NMN precursors)

SS-31 (Elamipretide)

Subcutaneous injection

Cycle Length

NAD+

Ongoing/indefinite

SS-31 (Elamipretide)

4-6 weeks

Onset Speed

NAD+

Moderate (1-2 weeks)

SS-31 (Elamipretide)

Moderate (1-2 weeks)

Evidence Level

NAD+

Moderate human trials (Phase 1-2)

SS-31 (Elamipretide)

Moderate human trials (Phase 1-2)

Efficacy

Benefit
ratings

NAD+
SS-31 (Elamipretide)

Cellular Energy

NAD+96%
SS-31 (Elamipretide)94%

Longevity Support

NAD+93%
SS-31 (Elamipretide)0%

Brain Function

NAD+88%
SS-31 (Elamipretide)0%

Mitochondrial Protection

NAD+0%
SS-31 (Elamipretide)97%

Anti-Oxidant (Targeted)

NAD+0%
SS-31 (Elamipretide)91%

Technical Data

Compound
specifications

NAD+

Molecular Formula

C21H27N7O14P2

Molecular Weight

663.4 g/mol

Half-Life

1-2 hours (plasma); tissue levels persist longer

Bioavailability

Variable by route: ~30% oral (precursors), ~100% IV

CAS Number

53-84-9

SS-31 (Elamipretide)

Molecular Formula

C32H49N9O5

Molecular Weight

639.8 g/mol

Half-Life

3-4 hours

Bioavailability

~92% (subcutaneous)

CAS Number

736992-21-5

Protocols

Dosing
tiers

NAD+

starting

250-300 mg NR or NMN daily

Once daily

4-8 weeks

Start with a lower dose to see how your body responds. Most people begin with oral precursors like nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN). Take in the morning with or without food.

standard

500-1000 mg NR or NMN daily

Once or twice daily

Ongoing

This is the most commonly used range in research studies. Some people split the dose (morning and early afternoon) for more consistent levels. Clinical trials have safely used up to 2000 mg daily.

advanced

250-500 mg IV NAD+ infusion

Weekly to monthly

Varies by protocol

IV infusions deliver NAD+ directly into your bloodstream, bypassing digestion. Sessions typically take 2-4 hours (slower = less flushing). Often used in clinical settings for intensive protocols or specific conditions.

SS-31 (Elamipretide)

starting

5-10 mg

Once daily

2-4 weeks

Begin with the lower dose to assess your tolerance. SS-31 is rapidly absorbed subcutaneously, typically reaching peak levels within 30-60 minutes. This conservative approach lets you gauge how your body responds before increasing.

standard

20-40 mg

Once daily

4-6 weeks

The 40 mg daily dose has been used in multiple clinical trials and represents the most studied protocol. This is the dosage that showed effects in heart failure and mitochondrial disease studies. Subcutaneous injection is the standard route.

advanced

40 mg

Once daily

8-12 weeks

Extended protocols for those with established tolerance under medical supervision. Some clinical trials have used 40 mg daily for 24+ weeks in specific patient populations. Do not exceed 40 mg daily—higher doses haven't shown additional benefits.

Applications

Best
suited for

NAD+

Healthy Aging Enthusiasts

NAD+ levels naturally decline 50% or more by middle age, and this drop is linked to many signs of aging. Boosting NAD+ helps maintain the cellular repair and energy production that keeps you feeling vital. It's like refilling your cells' gas tanks.

Brain Health Seekers

Your brain is an energy hog—it uses about 20% of your body's energy despite being only 2% of your weight. NAD+ supports the mitochondria that power your neurons, and research shows promising effects on cognitive function and neuroprotection.

Athletes and Active People

Every time you exercise, your muscles burn through NAD+ to produce energy. Boosting your NAD+ levels may help with recovery, endurance, and maintaining muscle function as you age. Many athletes notice improved workout recovery.

Metabolic Support Seekers

NAD+ plays a central role in how your body processes fats and sugars. Research shows it may help support healthy blood sugar levels, improve insulin sensitivity, and support weight management efforts when combined with a healthy lifestyle.

SS-31 (Elamipretide)

Mitochondrial Health Enthusiasts

If you're focused on optimizing cellular energy at the most fundamental level, SS-31 targets the actual machinery inside your mitochondria. It binds to cardiolipin—the special fat molecule that holds your electron transport chain together—keeping your cellular powerhouses running smoothly.

Aging Adults Concerned About Cellular Decline

Mitochondrial dysfunction is now recognized as a hallmark of aging. Your cells' energy factories get less efficient over time, producing more harmful byproducts. SS-31 helps protect and restore mitochondrial function, addressing one of the root causes of age-related decline.

Heart Health Supporters

Your heart is one of the most energy-demanding organs, packed with mitochondria. Clinical trials have studied SS-31 in heart failure patients because cardiac cells are especially vulnerable to mitochondrial dysfunction. Supporting heart mitochondria supports overall cardiovascular function.

Those Recovering from Oxidative Stress

Whether from intense exercise, illness, or environmental factors, oxidative stress damages your mitochondria from the inside out. SS-31 works as an antioxidant exactly where reactive oxygen species are produced—right at the inner mitochondrial membrane—neutralizing them before they cause harm.

Safety Profile

Side
effects

NAD+

Common

  • Flushing and warmth
  • Digestive upset
  • Mild headache

Uncommon

  • Increased energy or restlessness
  • Vivid dreams

Serious

  • Chest tightness during IV infusion

SS-31 (Elamipretide)

Common

  • Injection site reactions
  • Headache
  • Fatigue
  • Nausea

Uncommon

  • Dizziness
  • Flushing

Serious

  • Allergic reaction

Research Status

Safety
& evidence

NAD+

Evidence Level

Moderate human trials (Phase 1-2)

FDA Status

Not FDA approved

Safety Overview

NAD+ precursors like NR and NMN have demonstrated excellent safety profiles in human trials, with doses up to 2000-3000 mg daily being well-tolerated. The most common side effects are mild flushing (similar to niacin) and temporary digestive upset. IV NAD+ is more intense but also appears safe when administered properly by healthcare professionals.

Contraindications

  • xActive cancer (theoretical concern about fueling cancer cell metabolism)
  • xPregnancy or breastfeeding
  • xKnown allergy to niacin or B vitamins
  • xSevere liver disease

SS-31 (Elamipretide)

Evidence Level

Moderate human trials (Phase 1-2)

FDA Status

FDA approved for other use

Safety Overview

SS-31 (elamipretide) has demonstrated a favorable safety profile across multiple clinical trials, including studies lasting up to 24 weeks. The most common adverse events are mild injection site reactions. In September 2025, elamipretide received FDA approval for Barth syndrome, validating its safety in that population. Most side effects are mild to moderate and typically resolve with continued use or dose adjustment.

Contraindications

  • xPregnancy or planning pregnancy
  • xCurrently breastfeeding
  • xSevere kidney disease (peptide is renally excreted)
  • xKnown hypersensitivity to elamipretide or its components
  • xChildren and adolescents under 18

Decision Guide

Which is
right for you?

Choose NAD+ if...

  • Cellular energy and vitality
  • Healthy aging and longevity
  • Brain health and cognitive support
  • Metabolic optimization

Choose SS-31 (Elamipretide) if...

  • Mitochondrial health optimization
  • Cellular energy enhancement
  • Healthy aging support
  • Heart health maintenance